Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (321-330 of 522) with videos related to

Pageof 53
Sort By:
BJU International|October 23, 2018
Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseStephen J Freedland, Brandee L Branche, Lauren E Howard, et al.
BJU International|April 4, 2017
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancerLauren E Howard, Daniel M Moreira, Amanda De Hoedt, et al.
The Prostate|December 1, 2016
Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical ProstatectomyNima C Emami, Lancelote Leong, Eunice Wan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerThomas A Hope, Rahul Aggarwal, Bryant Chee, et al.
The Journal of Urology|January 4, 2022
The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate CancerMeera R Chappidi, Alexander Bell, Janet E Cowan, et al.
Urology Practice|May 5, 2023
The Impact of Comorbidity and Age on Timing of Androgen Deprivation Therapy in Men with Biochemical Recurrence after Radical ProstatectomyAriel Moradzadeh, Lauren E Howard, Stephen J Freedland, et al.
JCO Clinical Cancer Informatics|July 18, 2019
Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and ResearchAnobel Y Odisho, Mark Bridge, Mitchell Webb, et al.
European Urology|June 16, 2012
Active surveillance for prostate cancer: a systematic review of the literatureMarc A Dall'Era, Peter C Albertsen, Christopher Bangma, et al.
Histopathology|October 31, 2025
Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrenceNancy Y Greenland, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
Urology Practice|May 5, 2023
Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based CareFranklin D Gaylis, Matthew R Cooperberg, Stacy Loeb, et al.
Pageof 53

Showing results (321-330 of 522) with videos related to

Sort By:
Pageof 53
BJU International|October 23, 2018
Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseStephen J Freedland, Brandee L Branche, Lauren E Howard, et al.
BJU International|April 4, 2017
Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancerLauren E Howard, Daniel M Moreira, Amanda De Hoedt, et al.
The Prostate|December 1, 2016
Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical ProstatectomyNima C Emami, Lancelote Leong, Eunice Wan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate CancerThomas A Hope, Rahul Aggarwal, Bryant Chee, et al.
The Journal of Urology|January 4, 2022
The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate CancerMeera R Chappidi, Alexander Bell, Janet E Cowan, et al.
Urology Practice|May 5, 2023
The Impact of Comorbidity and Age on Timing of Androgen Deprivation Therapy in Men with Biochemical Recurrence after Radical ProstatectomyAriel Moradzadeh, Lauren E Howard, Stephen J Freedland, et al.
JCO Clinical Cancer Informatics|July 18, 2019
Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and ResearchAnobel Y Odisho, Mark Bridge, Mitchell Webb, et al.
European Urology|June 16, 2012
Active surveillance for prostate cancer: a systematic review of the literatureMarc A Dall'Era, Peter C Albertsen, Christopher Bangma, et al.
Histopathology|October 31, 2025
Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrenceNancy Y Greenland, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
Urology Practice|May 5, 2023
Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based CareFranklin D Gaylis, Matthew R Cooperberg, Stacy Loeb, et al.
Pageof 53